We are monitoring the impact of COVID-19 on MEA Autoimmune Diagnostics Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Autoimmune Diagnostics Market Research Report – Segmented By Test Type, Disease Type, End User and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Size, Share, Trends, Growth, Forecast (2022 to 2027)

Published: January, 2022
ID: 1130
Pages: 134

MEA Autoimmune Diagnostics Market Size (2022 to 2027)

The size of the Middle East and Africa Autoimmune Diagnostics Market was worth USD 0.60 billion in 2022 and estimated to reach USD 0.70 billion by the end of 2027, growing at a CAGR of 3.108% between 2022 to 2027.

Autoimmune diseases are an active hyperimmune response against their own body tissues and cells. Due to mergers and acquisitions that provide an increasing opportunity in this region. The most common autoimmune diseases include rheumatoid arthritis, type 1 diabetes, and multiple sclerosis.

The Middle East & Africa market is driven by the increasing prevalence of autoimmune disorders improving healthcare infrastructure.

Cost issues and problems of skilled manpower are the factors that hinder the growth of the market.

This research report is on the Middle East and Africa Autoimmune diagnostics market has been segmented & sub-segmented into the following categories:

By Test Type:

  • Autoantibody Tests
  • Antinuclear Antibody Tests
  • Complete Blood Count (CBC)
  • C-reactive protein (CRP) 
  • Comprehensive Metabolic panel  
  • Urinalysis 
  • Erythrocyte Sedimentation Rate (ESR)     
  • Others

By Disease Type:

  • Localized autoimmune disease diagnostics
    • Graves' Disease
    • Hashimoto's Thyroiditis
    • Multiple Sclerosis
    • Type 1 diabetes
    • Psoriasis
    • Others
  • Systemic autoimmune disease diagnostics
    • Rheumatoid Arthritis (RA)
    • Ankylosing Spondylitis
    • Systemic Lupus Erythematosus (SLE)

By End User:

  • Hospitals
  • Research Centres
  • Diagnostic Laboratories

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Companies like Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli Lilly and GlaxoSmithKline Plc are playing a notable role in the MEA autoimmune diagnostics market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Test Type                              

                                5.1.1 Autoantibody Tests             

                                5.1.2 Antinuclear Antibody Tests              

                                5.1.3 Complete Blood Count (CBC)          

                                5.1.4 C - reactive protein (CRP) 

                                5.1.5 Comprehensive Metabolic panel   

                                5.1.6 Urinalysis 

                                5.1.7 Erythrocyte Sedimentation Rate (ESR)        

                                5.1.8 Others      

                5.2 By Disease Type                       

                                5.2.1 Localized auto immune disease diagnostics              

                                                5.2.1.1 Graves' Disease

                                                5.2.1.2 Hashimoto's Thyroiditis

                                                5.2.1.3 Multiple Sclerosis

                                                5.2.1.4 Type 1 diabetes

                                                5.2.1.5 Psoriasis

                                                5.2.1.6 Others

                                5.2.2 Systemic auto immune disease diagnostics

                                                5.2.2.1 Rheumatoid Arthritis (RA)

                                                5.2.2.2 Ankylosing Spondylitis

                                                5.2.2.3 Systemic Lupus Erythematosus (SLE)

                5.3 By End Users                             

                                5.3.1 Hospitals  

                                "5.3.2 Research centers

 

"             

                                5.3.3 Diagnostic laboratories      

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bio-Rad                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Siemens Healthcare                

                8.3 Abbott Laboratories               

                8.4 Crescendo Bioscience                            

                8.5 Roche Diagnostics                    

                8.6 SQI Diagnostics                         

                8.7 AESKU Diagnostics                   

                8.8 INOVA Diagnostics                  

                8.9 BioMerieux SA                          

                8.10 Beckman Coulter Inc.                           

                8.11 Hemagen Diagnostics                          

                8.12 Quest Diagnostics                  

                8.13 Eli lilly                         

                8.14 Glaxosmithkline Plc                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. ​​​​​​Middle East & Africa Autoimmune diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  2. Middle East & Africa Autoimmune diagnostics Market, By Test Type, From 2022 - 2027 (USD Billion)
  3. Middle East & Africa Autoantibody Tests Market, By Region, From 2022 - 2027 (USD Billion)
  4. Middle East & Africa Antinuclear Antibody Tests Market, By Region, From 2022 - 2027 (USD Billion)
  5. Middle East & Africa Complete Blood Count (CBC) Market, By Region, From 2022 - 2027 (USD Billion)
  6. Middle East & Africa C - reactive protein (CRP) Market, By Region, From 2022 - 2027 (USD Billion)
  7. Middle East & Africa Comprehensive Metabolic panel Market, By Region, From 2022 - 2027 (USD Billion)
  8. Middle East & Africa Urinalysis Market, By Region, From 2022 - 2027 (USD Billion)
  9. Middle East & Africa Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2022 - 2027 (USD Billion)
  10. Middle East & Africa Other Test Types Market, By Region, From 2022 - 2027 (USD Billion)
  11. Middle East & Africa Autoimmune diagnostics Market, By Disease Type, From 2022 - 2027 (USD Billion)
  12. Middle East & Africa Localized Autoimmune Diseases Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  13. Middle East & Africa Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  14. Middle East Autoimmune diagnostics Market, By Test Type, From 2022 - 2027 (USD Billion)
  15. Middle East Autoimmune diagnostics Market, By Disease Type, From 2022 - 2027 (USD Billion)
  16. Africa Autoimmune diagnostics Market, By Test Type, From 2022 - 2027 (USD Billion)
  17. Africa Autoimmune diagnostics Market, By Disease Type, From 2022 - 2027 (USD Billion)
  18. Middle East & Africa Localized Autoimmune Disease Diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  19. Middle East & Africa Graves' Disease Market, By Region, From 2022 - 2027 (USD Billion)
  20. Middle East & Africa Hashimoto's Thyroiditis Market, By Region, From 2022 - 2027 (USD Billion)
  21. Middle East & Africa Multiple Sclerosis Market, By Region, From 2022 - 2027 (USD Billion)
  22. Middle East & Africa Type 1 diabetes Market, By Region, From 2022 - 2027 (USD Billion)
  23. Middle East & Africa Psoriasis Market, By Region, From 2022 - 2027 (USD Billion)
  24. Middle East & Africa Other Localized Autoimmune Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  25. Middle East Localized Autoimmune Disease Diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  26. Africa Localized Autoimmune Disease Diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  27. Middle East & Africa Systemic Auto-immune disease diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  28. Middle East & Africa Rheumatoid Arthritis (RA) Market, By Region, From 2022 - 2027 (USD Billion)
  29. Middle East & Africa Ankylosing Spondylitis Market, By Region, From 2022 - 2027 (USD Billion)
  30. Middle East & Africa Systemic Lupus Erythematosus (SLE) Market, By Region, From 2022 - 2027 (USD Billion)
  31. Middle East Systemic Auto-immune disease diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  32. Africa Systemic Auto-immune disease diagnostics Market, By Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample